Free Trial

BridgeBio Pharma (BBIO) Earnings Date, Estimates & Call Transcripts

BridgeBio Pharma logo
$23.41
-0.38 (-1.60%)
(As of 10/31/2024 ET)

Earnings Summary

Upcoming
Earnings Date
Nov. 7Estimated
Actual EPS
(Aug. 1)
-$0.39 Beat By $0.61
Consensus EPS
(Aug. 1)
-$1.00
Skip Charts & View Estimated and Actual Earnings Data

BBIO Earnings Estimates and Actuals by Quarter

The chart below shows up to four years of a company's earnings history. The dark blue line represents the company's actual earnings per share. The light blue area represents the range of Wall Street analysts' earnings estimates for each quarter.

BBIO Estimated and Actual Revenue by Quarter

The chart below shows up to four years of a company's revenue history. The dark blue line represents the company's actual revenue. The light blue line represents the company's estimated revenue based on the consensus of Wall Street analysts for each quarter.

BridgeBio Pharma Analyst EPS Estimates

QuarterNumber of EstimatesLow EstimateHigh EstimateAverage Estimate
Q1 20242($0.84)$0.44($0.20)
Q2 20242($0.99)($0.92)($0.96)
Q3 20242($0.99)($0.92)($0.96)
Q4 20242($1.35)($0.90)($1.13)
FY 20248($4.17)($2.30)($3.24)
Q1 20251($0.91)($0.91)($0.91)
Q2 20251($0.87)($0.87)($0.87)
Q3 20251($0.86)($0.86)($0.86)
Q4 20251($0.89)($0.89)($0.89)
FY 20254($3.53)($3.53)($3.53)

BBIO Earnings Date and Information

BridgeBio Pharma last posted its earnings results on August 1st, 2024. The reported ($0.39) earnings per share for the quarter, beating the consensus estimate of ($1.00) by $0.61. The firm had revenue of $2.17 million for the quarter, compared to the consensus estimate of $3.96 million. Its revenue for the quarter was up 32.1% on a year-over-year basis. BridgeBio Pharma has generated ($2.63) earnings per share over the last year (($2.63) diluted earnings per share). Earnings for BridgeBio Pharma are expected to decrease in the coming year, from ($2.56) to ($3.25) per share. BridgeBio Pharma has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 7th, 2024 based off prior year's report dates.

BridgeBio Pharma Earnings History by Quarter

DateQuarterConsensus EstimateReported EPSBeat/MissGAAP EPSRevenue EstimateActual RevenueLinks
11/7/2024
(Estimated)
------- 
8/1/2024Q2 2024($1.00)($0.39)+$0.61($1.65)$3.96 million$2.17 million  
5/2/2024Q1 2024($0.40)($0.05)+$0.35$0.10$140.06 million$211.12 million  
2/22/2024Q4 2023($0.87)($0.96)($0.09)($0.96)$4.78 million$1.74 million  
11/2/2023Q3 2023($0.86)($1.08)($0.22)($1.08)$5.29 million$4.09 million  
8/3/2023Q2 2023($0.80)($0.98)($0.18)($0.98)$2.99 million$1.60 million  
5/4/2023Q1 2023($0.83)($0.92)($0.09)($0.92)$3.23 million$1.83 million  
2/23/2023Q4 2022($0.86)($0.87)($0.01)($0.82)$12.24 million$1.87 million  
11/3/2022Q3 2022($1.02)($0.93)+$0.09($0.93)$6.26 million$0.34 million  
8/4/2022Q2 2022($0.92)($0.81)+$0.11($1.55)$29.96 million$73.75 million  
5/5/2022Q1 2022($1.13)($1.19)($0.06)($1.03)$4.47 million$1.69 million  
2/24/2022Q4 2021($0.83)($1.01)($0.18)($1.01)$21.58 million$12.89 million  
11/4/2021Q3 2021($0.91)($1.06)($0.15)($1.06)$16.12 million$2.34 million  
8/5/2021Q2 2021($0.97)($0.66)+$0.31($0.66)$24.93 million$54.00 million  
5/6/2021Q1 2021($0.83)($1.18)($0.35)($1.18)$21.91 million$0.46 million  
2/24/2021Q4 2020($0.86)($1.01)($0.15)($1.01)$15.34 million$0.12 million  
11/5/2020Q3 2020($0.90)($0.98)($0.08)($0.98)$17.25 million$8.13 million  
8/11/2020Q2 2020($0.76)($1.03)($0.27)($1.03)--  
5/13/2020Q1 2020($0.6890)($0.78)($0.0910)($0.78)--  
3/2/2020Q4 2019($0.70)($0.62)+$0.08($0.62)-$13.82 million  
11/7/2019Q3($0.55)($0.51)+$0.04($0.51)-$26.74 million  

BridgeBio Pharma Earnings - Frequently Asked Questions

When is BridgeBio Pharma's earnings date?

BridgeBio Pharma has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 7th, 2024 based off last year's report dates. Learn more on BBIO's earnings history.

Did BridgeBio Pharma beat their earnings estimates last quarter?

In the previous quarter, BridgeBio Pharma (NASDAQ:BBIO) reported ($0.39) earnings per share (EPS) to beat the analysts' consensus estimate of ($1.00) by $0.61. Learn more on analysts' earnings estimate vs. BBIO's actual earnings.

How much revenue does BridgeBio Pharma generate each year?

BridgeBio Pharma (NASDAQ:BBIO) has a recorded annual revenue of $219.12 million.

How much profit does BridgeBio Pharma generate each year?

BridgeBio Pharma (NASDAQ:BBIO) has a recorded net income of -$643.20 million. BBIO has generated -$2.63 earnings per share over the last four quarters.

What is BridgeBio Pharma's EPS forecast for next year?

BridgeBio Pharma's earnings are expected to decrease from ($2.56) per share to ($3.25) per share in the next year.


`

More Earnings Resources from MarketBeat


This page (NASDAQ:BBIO) was last updated on 10/31/2024 by MarketBeat.com Staff
From Our Partners